BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11346865)

  • 1. A case-control study of unilateral and bilateral breast carcinoma patients.
    Newman LA; Sahin AA; Cunningham JE; Bondy ML; Mirza NQ; Vlastos GS; Whitman GJ; Brown H; Buchholz TA; Lee MH; Singletary SE
    Cancer; 2001 May; 91(10):1845-53. PubMed ID: 11346865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
    Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer.
    Takahashi H; Watanabe K; Takahashi M; Taguchi K; Sasaki F; Todo S
    Breast Cancer; 2005; 12(3):196-202. PubMed ID: 16110289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of synchronous and metachronous bilateral breast cancer.
    Kollias J; Ellis IO; Elston CW; Blamey RW
    World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
    Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
    Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous and metachronous bilateral breast cancer: A long-term experience.
    Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
    J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers.
    Kadioğlu H; Özbaş S; Akcan A; Soyder A; Soylu L; Koçak S; Cantürk NZ; Tükenmez M; Müslümanoğlu M
    World J Surg Oncol; 2014 Aug; 12():266. PubMed ID: 25143016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases.
    Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F
    Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
    Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
    Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer.
    Schulze AK; Hoskin TL; Moldoveanu D; Sturz JL; Boughey JC
    Ann Surg Oncol; 2024 Feb; 31(2):947-956. PubMed ID: 37906382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
    Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Udvarhelyi N; Bak M; Kovács T; Mátrai Z
    Eur J Surg Oncol; 2016 Dec; 42(12):1814-1820. PubMed ID: 27424787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of early-stage synchronous bilateral invasive breast cancer.
    Schmid SM; Pfefferkorn C; Myrick ME; Viehl CT; Obermann E; Schötzau A; Güth U
    Eur J Surg Oncol; 2011 Jul; 37(7):623-8. PubMed ID: 21628090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes.
    Winchester DJ; Chang HR; Graves TA; Menck HR; Bland KI; Winchester DP
    J Am Coll Surg; 1998 Apr; 186(4):416-22. PubMed ID: 9544955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
    Freeman AB; Huang B; Dragun AE
    Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
    King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
    J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.
    Mattos D; Gfrerer L; Ling IT; Reish RG; Hughes KS; Halpern EF; Cetrulo C; Colwell AS; Winograd JM; Yaremchuk MJ; Austen WG; Liao EC
    Ann Surg Oncol; 2016 Mar; 23(3):767-75. PubMed ID: 26577123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated preoperative serum ICTP is a prognostic factor for overall and disease-free survival in breast cancer.
    Keskikuru R; Bloigu R; Risteli J; Kataja V; Jukkola A
    Oncol Rep; 2002; 9(6):1323-7. PubMed ID: 12375042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.